Cargando…

Social, Economic, and Medical Factors Associated With Solifenacin Therapy Compliance Among Workers Who Suffer From Lower Urinary Tract Symptoms

PURPOSE: The prevalence of hyperactive-type lower urinary tract symptoms is 45.2%, with shares of overactive bladder (OAB) and urge incontinence (UI) symptoms of 10.7% and 8.2%, respectively. We investigated the possible impact of a wide range of social, economic, and medical factors on compliance w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kosilov, Kirill Vladimirovich, Alexandrovich, Loparev Sergay, Gennadyevna, Kuzina Irina, Viktorovna, Shakirova Olga, Sergeevna, Zhuravskaya Natalia, Ivanovich, Ankudinov Ivan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Continence Society 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083827/ https://www.ncbi.nlm.nih.gov/pubmed/27706009 http://dx.doi.org/10.5213/inj.1632520.260

Ejemplares similares

Long-term adherence to antimuscarinic drugs when treating overactive bladder in the older: Subjective reason and objective factors
por: Kosilov, Kirill Vladimirovich, et al.
Publicado: (2017)

Influence of the Short-term Intake of High Doses of Solifenacin and Trospium on Cognitive Function and Health-Related Quality of Life in Older Women With Urinary Incontinence
por: Kosilov, Kirill, et al.
Publicado: (2018)

The efficacy of different doses of solifenacin in elderly patients after treating a urinary tract infection
por: Kosilov, Kirill V., et al.
Publicado: (2015)

Improvement of the symptoms of lower urinary tract and sexual dysfunction with tadalafil and solifenacin after the treatment of benign prostatic hyperplasia with dutasteride
por: Kosilov, Kirill V., et al.
Publicado: (2020)

A new tool for self-evaluation of adherence to antimuscarinic drugs treatment in patients with urinary incontinence
por: Kosilov, Kirill V., et al.
Publicado: (2017)

Efficacy of a combination of dutasteride, tadalafil, and solifenacin in the treatment of previously unsuccessful patients
por: Kosilov, Kirill, et al.
Publicado: (2022)

Corrigendum to “Efficacy of a combination of dutasteride, tadalafil, and solifenacin in the treatment of previously unsuccessful patients” [Asian J Urol 9 (2022) 42–50]
por: Kosilov, Kirill, et al.
Publicado: (2023)

Effectiveness of combined high–dosed trospium and solifenacin depending on severity of OAB symptoms in elderly men and women under cyclic therapy
por: Kosilov, Kirill, et al.
Publicado: (2014)

Influence of current state of executive function and working memory on adherence to antimuscarinic therapy in older women with OAB
por: Kosilov, Kirill, et al.
Publicado: (2019)

A review of solifenacin in the treatment of urinary incontinence
por: Basra, Ramandeep, et al.
Publicado: (2008)

Maintenance of the Therapeutic Effect of Two High-Dosage Antimuscarinics in the Management of Overactive Bladder in Elderly Women
por: Kosilov, Kirill, et al.
Publicado: (2013)

Solifenacin/Mirabegron Induces an Acute Compliance Increase in the Filling Phase of the Capacity-Reduced Urinary Bladder: A Pressure-Volume Analysis in Rats
por: Peng, Hsien-Yu, et al.
Publicado: (2021)

Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile Function
por: Seo, Deok Ha, et al.
Publicado: (2011)

Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia
por: Dimitropoulos, Konstantinos, et al.
Publicado: (2015)

Effect of Improvement in Lower Urinary Tract Symptoms on Sexual Function in Men: Tamsulosin Monotherapy vs. Combination Therapy of Tamsulosin and Solifenacin
por: Ko, Kyungtae, et al.
Publicado: (2014)

EGF, TGF-α and Amphiregulin Differently Regulate Endometrium-Derived Mesenchymal Stromal/Stem Cells
por: Kamentseva, Rimma Sergeevna, et al.
Publicado: (2023)

Combination of Luteolin and Solifenacin Improves Urinary Dysfunction Induced by Diabetic Cystopathy in Rats
por: Xu, Jing, et al.
Publicado: (2018)

Efficacy and safety of solifenacin plus tamsulosin oral controlled absorption system in men with lower urinary tract symptoms: a meta-analysis
por: Li, Ming-Chao, et al.
Publicado: (2015)

A Comparative Study on the Efficacy of Solifenacin Succinate in Patients with Urinary Frequency with or without Urgency
por: Han, Ji-Yeon, et al.
Publicado: (2014)

The Add-On Effect of Solifenacin for Patients with Remaining Overactive Bladder after Treatment with Tamsulosin for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction
por: Masumori, Naoya, et al.
Publicado: (2010)

Mirabegron and solifenacin are effective for the management of the increased urinary frequency induced by psychological stress in female mice
por: West, Eliza G., et al.
Publicado: (2022)

The Effect of Solifenacin on Cognitive Function following Stroke
por: Park, Jin-Woo
Publicado: (2013)

Spectrophotometric estimation of solifenacin succinate in tablet formulations
por: Singh, Lokesh, et al.
Publicado: (2011)

Comparison of solifenacin and fesoterodine in treatment of overactive bladder
por: Ercan, Önder, et al.
Publicado: (2015)

Influence of Temperature Parameters on Morphological Characteristics of Plasma Deposited Zinc Oxide Nanoparticles
por: Sazanova, Tatyana Sergeevna, et al.
Publicado: (2022)

Atlas of sentinel lymph nodes in early breast cancer using single-photon emission computed tomography: implication for lymphatic contouring
por: Novikov, Sergey Nikolaevich, et al.
Publicado: (2021)

Effects of Tamsulosin Combined With Solifenacin on Lower Urinary Tract Symptoms: Evidence From a Systematic Review, Meta-Analysis, and Trial Sequential Analysis of Randomized Controlled Trials
por: Song, Yuxuan, et al.
Publicado: (2020)

Men's Lower Urinary Tract Symptoms Are Also Mental and Physical Sufferings for Their Spouses
por: Kim, Sae Chul, et al.
Publicado: (2009)

Effectiveness of Solifenacin for Managing of Bladder Spasms in Patients With Urethroplasty
por: Peng, Xu Feng, et al.
Publicado: (2017)

Solifenacin-induced acute psychosis: a case report
por: Kirsavoglu, Betul, et al.
Publicado: (2021)

Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia
por: Nazir, Jameel, et al.
Publicado: (2015)

Treatment of Fissure Caries of Children with Severe Rheumatic Diseases with Difficulty in Opening the Mouth
por: Skakodub, Alla Anatolyevna, et al.
Publicado: (2022)

Pharmacokinetics comparison of solifenacin tartrate and solifenacin succinate: a randomized, open-label, single-dose, 2-way crossover study in healthy male volunteers
por: Kim, Yu-mi, et al.
Publicado: (2018)

Solifenacin significantly improves all symptoms of overactive bladder syndrome
por: CHAPPLE, C R, et al.
Publicado: (2006)

Are Solifenacin and Ramosetron Really Ideal to Treat Irritable Bowel Syndrome?
por: Chang, Full-Young
Publicado: (2012)

Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer’s Disease
por: Chase, Thomas N., et al.
Publicado: (2017)

Transcutaneous tibial neurostimulation and Solifenacin in urgent incontinence of postmenopausal women
por: Radinmehr, Hojjat, et al.
Publicado: (2023)

Transcutaneous electrical nerve stimulation and solifenacin succinate versus solifenacin succinate alone for treatment of overactive bladder syndrome: A double-blind randomized controlled study
por: Zhang, Yumeng, et al.
Publicado: (2021)

Solifenacin in Multiple Sclerosis Patients with Overactive Bladder: A Prospective Study
por: van Rey, Farida, et al.
Publicado: (2011)

Tamsulosin and Solifenacin in the Treatment of Benign Prostatic Hyperplasia in combination with overactive bladder
por: Wang, Hui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_713mas3cauiga3jqb05fgsbjj0